Mission Partners
6th Medical Logistics Management Center (6MLMC)
The 6th Medical Logistics Management Center (6th MLMC) provides centralized information management and logistics intelligence for medical material (Class VIII), and medical equipment maintenance to the 6 Combatant Commands. 6th MLMC is a direct reporting unit to US Army Forces Command (FORSCOM) under Administrative Control/Training Readiness Authority (ADCON/TRA) to the United States Army Medical Research and Materiel Command (MRMC) located at Fort Detrick, Md.
The 6th MLMC was established October 16, 2000, replacing the deactivated 6th Theater Medical Material Management Center. The 6th MLMC is composed of a base unit and two Early Entry/Forward Teams capable of forward deployment in support of Geographical and Functional Combatant Commands. The base unit links theater Class VIII commodity requirements with sourcing and distribution systems to get medical supplies and equipment into theater. The Early Entry/Forward Teams provide total asset and in-transit visibility for the medical commodity, both in the operational theater and en route to the deployed theater. Since 2001, the 6th MLMC has provide the core leadership team at the US Army Medical Materiel Center –Southwest Asia (USAMMC-SWA) (Provisional) located in Doha, Qatar, supporting Operation Enduring Freedom, Operation Iraq Freedom, Operation New Dawn. The 6th MLMC is a standing member of Joint Task Force – Civil Support (JTF-CS) in support of US NORTHCOM and is in a constant state of readiness to deploy in support of Defense Support of Civil Authorities (DSCA) missions such as the Haiti Earthquake and Hurricane Sandy.
In addition, the 6th MLMC integrates and coordinates strategic medical logistics actions between the theater(s) and the service agencies responsible for medical logistics. Our strategic business partners include: U.S. Army Medical Material Agency, U.S. Army Medical Material Center-Europe, U.S. Army Medical Material Center-Korea, U.S. Army Medical Material Center-Southwest Asia, Air Force Medical Logistics Office, Naval Medical Logistics Command, Defense Logistics Agency, and Defense Supply Center Philadelphia.
The 6th MLMC’s responsibilities include: Reviewing and analyzing demands and computing theater medical commodity requirements; evaluating the workload and capabilities; training Medical Logistics Units for deployment; implementing the use of standard Army maintenance and material systems for field medical units for FORSCOM and the Army Medical Logistics Enterprise (AMLE).
53rd Signal Battalion
The 53rd Signal Battalion, formerly 1st Satellite Control Battalion (SATCON), represents not only the growth in the importance of space and space-related products of the Army, but also the continuing growth of the U.S. Army Space And Missile Defense Command as it normalizes space support to the warfighter.
The first Wideband Satellite Operations Center, now operated by 53rd Signal Battalion, was built in 1981-82 at Fort Detrick. Over the last 25 years, Soldiers have pioneered the control techniques that are implemented hundreds of times each day by the battalion’s Soldiers.
The 53rd provides continuous, reliable, robust, worldwide communications support to U.S. warfighting forces, strategic military users, the U.S. intelligence community and the National Command Authority via the Defense Satellite Communications System (DSCS) and Wideband Global Satellite (WGS).
The company is responsible for the daily command and control of the DSCS using large earth terminal ground stations.
21st Signal Brigade
The 21st Signal Brigade is a major subordinate command of the 9th Signal Command (Army) (NETCOM/9th SC(A)). The original 21st Signal Group was constituted on 22 June 1965 in the Regular Army as the Headquarters and Headquarters Detachment, 21st Signal Group and activated on 1 September 1965 at Fort Bragg, North Carolina. The unit was headquartered at Nha Trang, Nha Trang, South ViSouth Vietnam and provided area signal communications support throughout 10,000 square miles of the I and II Corps tactical zones in South Vietnam, saw action throughout thirteen campaigns during the Vietnam War, received the Meritorious Unit Commendation, and was later inactivated on 27 November 1971 at Fort Lewis, Washington. The unit was reactivated on 16 October 2003, and designated the 21st Signal Brigade, headquartered at Fort Detrick, Maryland.
The 21st Signal Brigade’s mission is to provide Command, Control, Communications, and Computers (C4) systems support to the President, Secretary of Defense, Joint Chiefs of Staff, Department of Defense, Combatant Commanders and other Federal Agencies. To establish, operate, protect, and sustain the Army’s CONUS (Continental United States) strategic portion of the Global Information Grid. To protect and provide for the well-being of our people. The Brigade is headquartered at Fort Detrick, Maryland and has three subordinate battalions and one field activity: the 114th Signal Battalion located at Raven Rock Mountain Complex in Adams County, Pennsylvania, the 302d Signal Battalion headquartered at Fort Detrick, Maryland, and the 56th Signal Battalion and 7th Signal Center are located at Fort Gordon, Georgia.
www.7sigcmd.army.mil.21sb
114th Signal Battalion
The 114th Signal Battalion was originally activated as the 3364th Signal Service Battalion on 28 October 1944. The unit was part of the world-wide support structure provided to garrison and field forces during WWII by the Army Service Forces.
After providing key support to Army Air Forces operations and training at Miami Army Air Field, the unit was inactivated at Miami on 22 April 1946, having earned the Meritorious Unit Commendation Streamer (embroidered American Theater).
On 20 October 1959, the unit was re-designated as the 114th Signal Battalion and allotted to the Army Reserve. The unit was again activated on 26 October 1959 at Greensboro, North Carolina. After 9 years, the unit was again inactivated on 31 January 1968.
The 114th Signal Battalion was re-activated as a unit of the 21st Signal Brigade on 16 October 2003, at Fort Detrick, Maryland. At this time the 114th Signal Battalion assumed the 50-year old mission of the 1111th Signal Battalion, which was deactivated at Fort Detrick the same day. And for the first time, the 114th Signal Battalion received its own distinctive unit colors, insignia and coat of arms.
In June 2007, the 55 th Signal Company (Combat Camera) was once again placed under the operational and administrative control of the 114 th Signal Battalion.
On 20 May 2009, Headquarters Company was reorganized as two separate companies, Headquarters and Headquarters Detachment and Alpha Company, 114 th Signal Battalion.
In accordance with FDU 05-01 Alpha Company was deactivated on 8 April 2011, merging both Alpha Company and Headquarters and Headquarters Detachment into one authorized detachment.
114th Signal Battalion members are proud to be “Signal Masters of the Rock!”
302nd Signal Battalion
Constituted on 29 July 1921 in the Organized Reserves, the 302nd Signal Battalion was organized and outfitted in January 1922 at New York, New York. After the United States entered World War II, the battalion was redesignated the 302d Signal Operation Battalion on 8 December 1942, and ordered into active military service on 23 February 1943 at Camp Swift, Texas under Fifth Headquarters, Special Troops, Third Army. The battalion arrived at Avonmout, England on 9 March 1944, and was assigned to First United States Army Group (FUSAG), which was later renamed 12th Army Group under General Omar Bradley.
Between D-Day and VE Day, the battalion supported the Third Army and General Patton’s dash across France, Belgium, Luxembourg and Germany through five campaigns, receiving battle streamer credit for the Normandy, Northern France, Rhineland, and Central Europe campaigns. The 302d was the first US Army signal battalion to occupy Heidelberg, Germany in support of 12th Army Group during the initial phase of occupation and was later deactivated on 1 June 1946. The battalion was redesignated the 302d Signal Heavy Construction Battalion on 8 January 1947, and activated in Louisville, Kentucky on 17 January 1947. The battalion later moved to Philadelphia, Pennsylvania and remained there until 5 September 1950. The battalion was redesignated the 302d Signal Aviation Construction Battalion on 16 April 1951, and activated at Frederick, Maryland on 18 April 1951 and remained active there until 20 February 1963.
The 302d Signal Battalion was reactivated on 14 July 1969 in Bangkok, Thailand and supported operations in Southeast Asia through 30 June 1971 as part of 29th Signal Group, US Army Strategic Communications Command. Following the fall of the Berlin Wall, the battalion was reactivated in Karlsruhe, Germany and assumed the missions of the 160th Signal Brigade. The battalion was awarded the national streamer for Cold War Engagement from the Federal Republic of Germany in 1994, and deactivated later that same year on 15 September 1994 in Stuttgart, Germany. The 302d Signal Battalion was reactivated on 16 October 2003 at Ft. Detrick, Maryland as part of the 21st Signal Brigade. http://www.7sigcmd.army.mil/21SB/302SigBn/
U.S. Army Medical Research and Materiel Command (USAMRMC)
USAMRMC is a major subordinate command of the U.S. Army Medical Command responsible for lifecycle management of medical materiel, from basic laboratory research through advanced development, prototyping, procurement, delivery to units, maintenance and disposal. The USAMRMC is responsible for planning, programming and budgeting for construction of Army medical facilities and for corporate information management and information technology requirements of the Army Medical Department.
Headquartered at Fort Detrick, Md., the USAMRMC operates six medical research laboratories and institutes in the United States. These laboratories make up the core science and technology capability of the command. They are centers of excellence in specific areas of biomedical research, staffed by highly qualified military and civilian scientists and support personnel. The command’s in-house science and technology capabilities are enhanced by a large extramural contract research program and numerous cooperative research and development agreements with leading research and development organizations in the civilian sector.
The command also operates eight subordinate units exclusively focused on medical materiel development, contracting, medical logistics management, health facility planning, and information management and technology. Approximately 5,400 military, civilian and contractor personnel are assigned to the headquarters and 14 subordinate units. Officers, enlisted service members, and Civilians provide a wide variety of medical, scientific, and technical expertise. Many of these personnel are among the most respected and knowledgeable specialists in their fields.
In addition to eight elements at Fort Detrick, USAMRMC operates units at the Forest Glen Annex of the Walter Reed Army Medical Center, Silver Spring, Md.; Alexandria, Va.; Aberdeen Proving Ground, Md.; Natick, Mass.; Fort Rucker, Ala.; Fort Sam Houston, Texas; and Pirmasens, Germany. The Walter Reed Army Institute of Research, one of USAMRMC’s laboratories, operates overseas research units in Germany, Kenya, and Thailand.
The USAMRMC is the Department of Defense executive agent for medical chemical-and-biological defense research programs and combat maxillofacial surgery. It is also Defense Department lead agent for infectious disease research and military nutrition. Finally, it acts as the Department of Defense’s manager of congressionally mandated, peer-reviewed research programs in breast cancer, prostate cancer, ovarian cancer, neurofibromatosis and military women’s health.
The U.S. Army Medical Materiel Agency (USAMMA)
The U.S. Army Medical Materiel Agency (USAMMA) is headquartered at Fort Detrick, Maryland, with satellite medical maintenance operations and centrally managed prepositioned materiel sites located throughout the United States and overseas.
The USAMMA performs materiel acquisition project management and sustainment in support of strategic level missions and transformation goals of the U.S. Army and Military Health System.
We support the Army’s Medical Treatment Facilities (MTFs) and the medical field organizations (operational forces) across most functional areas: veterinary, preventive medicine, dental, hospitalization, area support (Roles 1 & 2), evacuation, medical laboratory and combat stress control. Two key elements of the USAMMA’s wartime support mission are the deployment of Medical Logistics Support Teams to issue centrally managed materiel in support of operational forces and a depot Forward Repair Activity-Medical (FRA-M) providing forward deployed medical maintenance expertise during contingency operations. The USAMMA also serves as the command case manager for Foreign Military Sales (FMS) and is the sole Army contact for the sale of complex, service-unique medical materiel.
Our various stakeholders, suppliers-partners and customer base consists of federal departments/agencies, the Department of Defense, allied Nations and industrial institutions. Our many products and services include the following:
Lifecycle management of medical materiel and project management for advanced development projects.
The USAMMA provides acquisition and related force management expertise as the materiel developer for commercial and non-developmental items, manager for integrated acquisition logistics and logistician for medical materiel lifecycle management in support of the operational force (TOE) and medical treatment facilities (TDA).
Equipping and sustaining the medical force. The USAMMA has myriad strategic roles that directly support the Army Campaign Plan (ACP) and the Army Force Generation (ARFORGEN). The programs include building medical sets kits and outfits (SKOs), fielding medical SKOs and equipment, providing medical maintenance and sustainment support to the Army around the globe and integrating new business projects and processes with current operations.
Managing medical strategic centralized programs. In support of force projection, the agency centrally manages several Army and OTSG readiness programs. These programs include the acquisition, storage, distribution and transfer of prepositioned stocks located ashore and afloat, as well as medical chemical defense packages and short shelf life pharmaceuticals and other materiel.
We denote our organizational motto: SEMPER RESPONSUS (Always Ready), in relentless pursuit of medical readiness.
The U.S. Army Medical Materiel Development Activity (USAMMDA)
The U.S. Army Medical Materiel Development Activity (USAMMDA) was established in 1985 to serve as the advanced development activity of medical products for the Department of Defense (DOD).
As the designated program manager for Combat Medical Systems, the USAMMDA develops and fields medical products for the U.S. Armed Forces in conjunction with the Army Medical Department (AMEDD) Center and School, the combat developer; the U.S. Army Medical Materiel Agency (USAMMA), the logistician; and other service inputs. USAMMDA product managers take promising new concepts and technologies developed in U.S. Army Medical Research and Materiel Command’s (USAMRMC) laboratories, guides them through the regulatory process to receive United States Food and Drug Administration (FDA) certification and develop plans for fielding medical material in conjunction with the USAMMA.
The USAMMDA has achieved an extraordinary level of success in the development and fielding of medical materiel, including developing equipment for diagnosis, treatment and evacuation of combat casualties and development of prophylactic and therapeutic drugs and vaccines to protect Service Members against infectious diseases and chemical/biological warfare threats. In addition to leveraging proven civilian technologies into military applications, the USAMMDA has been able to achieve its success through partnerships with industry, academia and other government agencies.
Mission: Develop and deliver quality medical solutions to protect, treat and sustain the health of our Service Members.
Vision: The USAMMDA is the premier developer of world class military medical solutions.
The USAMMDA is organized around five major project management offices and four executive and support divisions.
Project Management Offices (PMO)
Medical Support Systems (MSS) develops, tests, procures and sustains the best medical evacuation, combat casualty care support and operational and preventive medicine solutions for the Warfighter. MSS collaborates with other Army Program Executive Offices for integration of medical products on ground, air and Soldier platforms. The Medical Prototype Development Laboratory is a small team of engineering technicians who rapidly design and build prototype medical devices, and harden commercial off-the-shelf products for use in a field environment.
Pharmaceutical Systems centrally manages the development and acquisition of pharmaceutical and biological products (drugs, vaccines, diagnostics, protective and therapeutic modalities for use against infectious diseases and similar products for combat casualty care). Product managers work with USAMRMC laboratories, academia and industry partners (both domestic and foreign) to identify, develop, license and field products to remedy deficiencies identified by the Army Medical Department Combat Developer.
Tissue Injury and Regenerative Medicine (TIRM) oversees the development of innovative therapeutic solutions to address catastrophic injuries incurred by our Warfighters. The TIRM PMO receives funding from the USAMRMC; the U.S. Navy, Office of Naval Research; the U.S. Air Force, OTSG; the National Institutes of Health; the Office of the Assistant Secretary of Defense for Health Affairs; and the Veterans Administration. This enables the TIRM PMO to support dynamic, interdisciplinary collaborations between academic, government and industry partners who are recognized leaders in the fields of regenerative medicine and tissue repair research who work toward the goal of making Warfighters whole by restoring form and function.
Hyperbaric Oxygen (HBO2) Treatment for mild Traumatic Brain Injury (mTBI) is the administration of oxygen in a chamber at greater than sea-level atmospheric pressure in which oxygen becomes increasingly dissolved in the blood, resulting in greater than normal every day oxygen tension in cells and tissues in the body. There is some compelling anecdotal evidence to suggest this may be beneficial in the treatment of acute and chronic symptoms linked to Traumatic Brain Injury. Stronger evidence must be obtained prior to determining whether HBO2 should be used as a treatment for TBI.
Neurotrauma and Psychological Health (NPH) was formed in May 2011 to support advanced development of materiel and select nonmateriel (medical knowledge) products to protect, sustain and care for Warfighters with TBI and psychological health issues including Post-Traumatic Stress Disorder. Additionally, NPH provides advanced development assistance to the USAMRMC Military Operational Medicine and Combat Casualty Care Research Programs and associated Joint Program Committees.
Support Divisions
The Division of Regulated Activities and Compliance (DRAC) is a multidisciplinary team of regulatory affairs and compliance professionals dedicated to supporting the USAMMDA mission of developing medical products for the Warfighter on point for the Nation. The DRAC provides full-service regulatory support for products through the DOD acquisition spectrum, from individual investigator-initiated clinical studies to products in the advanced development pipeline. The DRAC carries out its delegated responsibilities as the Office of The Surgeon General (OTSG) sponsor’s representative for the Army regarding medical materiel development, and its operations are mandated in FDA, DOD and Army regulatory requirements. The DRAC supports investigators at medical centers and laboratories, institutional review boards and product development teams in laboratories and advanced development organizations throughout the Army and the DOD. The DRAC also has the only electronic Common Technical Document capability for submissions to the FDA in electronic format.
The Clinical Service Support Division supports the development of medical products by providing expert assistance in the areas of IND product manufacturing, testing and accountability; clinical study monitoring; clinical data management; biostatistics, including study design and data analysis; and adverse event monitoring and reporting.
The Administrative Services Division provides overall management, administrative, budgeting and information technology support to ensure the smooth function of the operational divisions.
Executive Agency
Force Health Protection (FHP)-IND is an executive agency under the Army OTSG. FHP provides services to all DoD Components as the lead organization for using medical products under emergency use authorizations or IND applications in response to chemical, biological, radiological, nuclear warfare or terrorism and other health threats. FHP provides an urgent treatment capability using novel investigational countermeasures to protect U.S. forces against man-made or natural threats in accordance with federal regulations and DOD instructions.
Critical Tasks:
• Provide a safe and compliant program to protect U.S. forces using IND countermeasures.
• Provide logistical support for the unique requirements for acquisition, storage, shipping and testing of investigational countermeasures.
• Deploy personnel and investigational countermeasures in support of civilian authorities or military commanders.
For more information, visit: www.usammda.army.mil.
U.S. Army Medical Research Acquisition Activity (USAMRAA)
USAMRAA provides contracting and assistance agreement award support to the U.S. Army Medical Research and Materiel Command (USAMRMC), Command Headquarters and its worldwide network of laboratories and medical logistics organizations. USAMRAA also supports the Fort Detrick Garrison and many of its military tenant activities, Army-wide projects sponsored by the Army Surgeon General, and numerous congressionally mandated programs.
U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)
Since its inception in 1969, the USAMRIID has spearheaded research to develop medical solutions—such as vaccines, drugs, diagnostics and information—to protect U.S. Service Members from biological threats. The institute’s unique capabilities include Biosafety Level (BSL)-3 and -4 laboratories, world-class expertise in the generation of biological aerosols for testing candidate vaccines and therapeutics and fully accredited animal research facilities.
Most people know the USAMRIID by its continuing involvement in supporting investigations of emerging diseases throughout the world, including the Ebola virus, Middle East Respiratory Syndrome (MERS), H1N1 influenza, Severe Acute Respiratory Syndrome (SARS), West Nile virus and Venezuelan equine encephalitis, to name a few. Colleagues at the Centers for Disease Control and Prevention, the World Health Organization and other agencies know the USAMRIID as a reference laboratory that sets the standard for identification of biological agents. Customers in the Army and the Department of Defense know the USAMRIID as a “tech base” organization that has produced some 20 candidate medical products over the past decade. Still others recognize the impressive scientific credentials of the institute’s workforce, which represents some of the top infectious disease and biological defense experts in the Nation—indeed, in the world.
As the cornerstone of the National Interagency Biodefense Campus at Fort Detrick, the USAMRIID will continue its collaborations with the National Institute of Allergy and Infectious Diseases, the Department of Homeland Security and many other partners conducting research for civilian biodefense.
The new USAMRIID facility, adjacent to the existing Building 1425, will expand the institute’s capacity to test products developed by its partners in biodefense research; incorporate newer technologies for developing vaccines, drugs and diagnostics; and better accommodate the workforce, which has more than doubled since the program began.
While the USAMRIID’s primary focus is on protecting military Service Members, its research has applications that benefit society as a whole. The institute’s unique science and technology base serves not only to address current threats to our Armed Forces, but is an essential element in the medical response to any future biological threats that may confront our Nation.
Walter Reed Army Institute of Research (WRAIR)
The mission of WRAIR is to conduct biomedical research that is responsive to DoD and U.S. Army requirements and delivers life-saving products including knowledge, technology, and medical materiel that sustain the combat effectiveness of the Warfighter.
With its headquarters dedicated to Senator Daniel E. Inouye and located in Silver Spring, Maryland, the Walter Reed Army Institute of Research is the largest biomedical research facility currently serving the Department of Defense. Established in 1893, research and development now reaches around the world from Maryland to Germany, Thailand, Kenya and the Republic of Georgia.
WRAIR’s vision is to be the premier DoD biomedical research organization, constantly relevant, integrating basic research and advanced technology that protects, projects, and sustains the Warfighter today, invents global medical solutions for the future, and keeps the Warfighter on point for the Nation. WRAIR houses Centers of Excellence for Military Psychiatry and Neuroscience Research and for Military Infectious Disease Research. In addition to the Centers, WRAIR has two other important divisions. The Translational Medicine division is comprised of a clinical trials center, a pilot bioproduction facility and special services related to regulatory affairs when products are in development.
The Center for Military Psychiatry & Neuroscience is comprised of 5 branches:
• The Military Psychiatry branch focuses on research to improve Service Member resilience, understand the impact of combat on mental health, aid in assessing whether needed mental health services are available to Service Members in theater and enhance understanding of post-deployment mental health impacts.
• The Behavioral Biology branch is world-renowned in research on sleep, investigating and developing methods of optimizing warfighter alertness, performance and resilience through evidence-based approaches.
• The Brain Trauma, Neuroprotection & Neuroplasticity branch aims to address traumatic brain injury or TBI and its immediate and longer-term consequences through therapeutics and diagnostics to prevent or lessen cognitive and physical disabilities, seizure disorders, and the potential for chronic traumatic outcomes.
• The Blast-induced Neurotrauma branch researches the complexity of blast TBI to discover and advance therapies or policy changes to improve survival and functional outcomes for those Service Members exposed to blasts.
• Research Transition Office translates the findings of each of the 4 branches into recommendations and policies in support of the Army’s operational requirements.
The Center for Infectious Disease Research has branches based on specific disease emphases or research needs related to vector-borne diseases:
• The Bacterial Disease branch focuses broadly on various bacterial infections that affect Service Members such as enteric pathogens and wound infections but also tracks emerging and changing bacterial pathogens around the world.
• The Military Malaria Research Program is developing malaria vaccines for disease prevention, antimalarial drugs for prevention and treatment and diagnostic tools and training where needed.
• The Military HIV Research Program is multifaceted in support of the Army mission for HIV screening and surveillance, diagnosis, HIV vaccine research and HIV prevention, care and treatment through the President’s Emergency Plan for AIDS relief. Operations include research sites in Kenya, Tanzania, Uganda, Mozambique, Nigeria and Thailand.
• The Entomology branch works to understand the vectors that spread diseases such as sand flies (carrying Leishmania), mosquitoes (malaria, dengue, yellow fever, West Nile virus, and Japanese encephalitis) and more, sometimes conducting studies at the overseas laboratories. Entomology includes an in-house insectary for many species needed for studies in other branches of the Center.
• The Viral Diseases branch has a storied history in developing vaccines for many viral diseases such as hepatitis A, Japanese encephalitis, adenoviruses, and many more. Studies are underway to develop a single dengue vaccine for the four disease-causing serotypes.
• The Preventive Medicine branch is not just focused on infectious diseases but researches all aspects of preventive medicine unique to a military population.
Major recent accomplishments of the Walter Reed Army Institute of Research:
• Instrumental in the development of the first malaria vaccine (RTS,S) to show efficacy against both clinical and severe malaria
• Contributed to the development of Comprehensive Soldier Fitness in the area of psychological resilience for combat stress
• Contributed to the development of virtually every antimalarial drug available today
• Operates the only College of American Pathologist’s accredited Leishmania diagnostic laboratory in the world
• Through the Military HIV Research Program (MHRP), first identified HIV-1 heterosexual transmission and showed efficacy of an HIV vaccine
• Developed a new Japanese Encephalitis and Hepatitis A vaccine
Collaboration is a critical component of research and development and the WRAIR prides itself on the work accomplished through our numerous partnerships.
For WRAIR’s overseas laboratories, please see more at their websites:
• U.S. Army Medical Research Unit-Europe (USAMRU-E), Sembach, Germany: http://usamru-e.amedd.army.mil/
• U.S. Army Medical Component – Armed Forces Institute of the Medical Sciences(USAMC-AFRIMS), Bangkok, Thailand (headquarters): www.afrims.org
• U.S. Army Medical Research Unit (USAMRU-K),Nairobi, Kenya (headquarters): www.usamrukenya.org
• U.S. Army Medical Research Unit—Georgia
Walter Reed Army Institute of Research
503 Robert Grant Avenue
Silver Spring, Maryland 20910
Visit us at www.wrair.army.mil
On Twitter @WRAIR
Public Affairs at (301) 319-9471
E-mail: usarmy.detrick.medcom-wrair.mbx.public-affairs@mail.mil
Air Force Medical Evaluation
Support Activity
The Air Force Medical Evaluation Support Activity (AFMESA), a division of the Air Force Medical Support Agency, is dedicated to advancing Air Force health care through independent operational testing of medical technologies and information systems. AFMESA operates in Area B that includes a dedicated test Expeditionary Medical Support (EMEDS+10) hospital and a gravel test pad. The AFMESA main desk can be reached at (301) 619-8600.
Air Force Medical Operations Agency - Air Force Medical Logistics Division
The Air Force Medical Logistics Division of the Air Force Medical Operations Agency (AFMOA/SGAL), plans, programs and provides AF medical expeditionary capabilities to support the national security strategy. They define and execute health care policy for 43K personnel at 75 MTFs with a $6.1B budget, ensure a cost-effective, patient-centered and prevention-based health care continuum for 2.1M beneficiaries worldwide. They direct $370M AF War Reserve Materiel program and support 120 equipment allowance standards valued at $88M. They build strategic partnerships with DOD/ASD(HA), VA, federal agencies, academia and allied medical services.
Air Force Medical Operations Agency (AFMOA)- Expeditionary Medical Skills Division
The Air Force Medical Operations Agency (AFMOA)- Expeditionary Medical Skills Division (ASMOA/SG3XS) reports to the Assistant Surgeon General, Healthcare Operations, Office of the Air Force Surgeon General. Its mission is to establish policy and guidance for global medical support training, exercises and personnel deployment planning requirements; orchestrate resources necessary to accomplish medical readiness training; perform as the active component subject matter experts for development and management of medical readiness information systems; and to act as the Air Force/Surgeon General’s consultant to the modeling and simulation community to predict the resource demands of deployed personnel.
AFMSA/SGPX collaborates with numerous organizations and resources to meet their mission. These resources include the U.S. Army Medical Research Acquisition Activity, Telemedicine and Advanced Technology Research Center, the acquisition community, major air commands, joint medical readiness planners, Air Force Surgeon General clinical consultants, and the Air Force modeling, simulation and analysis community.
AFMSA/SGPX also works closely with the DMSB to establish Joint Service policies governing casualty management and standardization of medical material assets.
Armed Forces Pest Management Board
The Armed Forces Pest Management Board, or AFPMB, is a Department of Defense function under the direction of the Office of the Deputy Under Secretary of Defense for Installations and Environment. AFPMB ensures deployed combat forces have the most effective disease vector control and pest management capabilities to prevent adverse effects on troops, weapons systems, supplies, equipment and installations, using environmentally sound techniques to reduce risk.
A senior officer selected from one of the military service branches directs AFPMB; duty rotates among the services. Army, Navy, and Air Force officers and scientists staff it jointly. The AFPMB offices, located at Forest Glen, include two sections: the Directorate and the Defense Pest Management Information Analysis Center. The AFPMB Web site is www.afpmb.org.
Company B, 4th Light Armored Reconnaissance Battalion
Company B, 4th Light Armored Reconnaissance Battalion was activated on October 4, 1987 aboard Fort Detrick in Frederick, Maryland. Bravo Company is a part of the United States Marine Corps Reserves. Headquartered under 4th Light Armored Reconnaissance Battalion in Camp Pendleton, California, Bravo Company is organized to deploy independently or as part of a larger Marine Air Ground Task Force. The Marine Corps Reserves’ purpose is to augment and reinforce the Active Component with trained units and individual Marines as a sustainable and ready operational reserve for employment across the full spectrum of crisis and global engagement.
The mission of 4th Light Armored Reconnaissance Battalion is to perform combined arms reconnaissance and security missions in support of the Ground Combat Element (GCE) of a Marine Air-Ground Task Force (MAGTF). Its mission is to conduct reconnaissance, security and economy of force operations, and, within its capabilities, limited offensive or defensive operations that exploit the unit’s mobility and firepower.
Bravo Company has deployed to Kuwait and Iraq in 1990 in support of Operation Desert Shield and Operation Desert Storm, to Iraq in 2003 and 2006 in support of Operation Iraqi Freedom, and to Afghanistan in 2009 in support of Operation Enduring Freedom.
Frederick National Laboratory (FNL)
Frederick National Laboratory for Cancer Research partners with university, government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS.
With a unique array of advanced technologies, FNL is bridging the gap between discovery and healthcare delivery. FNL focuses on projects that cannot be effectively achieved by other means. FNL assesses research for its value to patients. FNL accelerates the development of new technologies and prototype treatments for patients. FNL also paves the way for new advances to enter clinically trials for testing, approval and delivery to patients via the commercial sector.
Civilian Personnel Advisory Center (CPAC)
The Civilian Personnel Advisory Center is located at 1541 Porter Street. The office provides civilian personnel services to managers, supervisors, employees and individuals seeking employment. These services include the full range of personnel management functions, including recruitment, management-employee relations, and labor relations.
The office is open Monday - Friday from 8 a.m. - 4 p.m., and can be reached by telephone at (301) 619-2247. Job postings are listed on the website: www.usajobs.gov
Congressionally Directed Medical Research Programs (CDMRP)
The beginning of the Congressionally Directed Medical Research Programs can be traced to the early 1990s when a grass roots advocacy movement campaigned for an increase in breast cancer research funding. The U.S. Congress responded with an initial appropriation of $25 million in 1992 to be managed by the Department of Defense’s U.S. Army Medical Research and Materiel Command (USAMRMC). The following year, Congress appropriated $210 million to the Department of Defense for a competitive peer reviewed breast cancer research program, thereby establishing the CDMRP.
Since then, the CDMRP has evolved into a global funding organization for biomedical research that spans many different research areas including many cancers (breast, lung, ovary, prostate, etc.), neurological conditions (neurofibromatosis, ALS, Alzheimer’s, tuberous sclerosis, epilepsy, Parkinson’s, etc.), as well as clinical and rehabilitative medicine (vision, orthotics and prosthetics, etc.), each targeting a specific public and/or military need. In addition, the CDMRP works with the Defense Health Agency Joint Program Committees to execute extramural programs focusing on military-related research (traumatic brain injury, psychological health, orthopedic, spinal cord injury, etc.). The CDMRP has grown in size and scope, becoming the USAMRMC Execution Management Agency In 2014. To date the CDMRP is responsible for managing $8.7 billion in appropriations and funding over 12,400 research awards.
Funding high-impact, cutting-edge research to improve the function, wellness and overall quality of life for military Service Members, as well as their caregivers, families and the American public, is the thrust of the CDMRP’s programs. Being highly responsive to the current needs in each of its program’s disease or conditions communities, the CDMRP funds a wide spectrum of basic to applied clinical research to clinical trials. Each program’s funding strategy is adapted on a yearly basis to meet emerging needs of the patient and research communities, gaps in research and other barriers to progress in curing, rehabilitating or eliminating the disease or condition.
Several features unique to the CDMRP research programs are: 1) funding research that is focused exclusively on the disease, condition or injury, as specified in congressional language; 2) integrating survivors and advocates into every aspect of the program management cycle; and 3) employing a two-tier review that includes a traditional technical merit review followed by programmatic review, which distinguishes this review process from strictly pay-line funding and allows each program to fund research that best meets its goals and vision.
The CDMRP strives to find and fund the best research for the benefit of the Warfighter and the American public while also ensuring the integrity of the public trust and providing transparency by making award information available to the public through a “Search Awards” feature, and downloadable program booklets and Annual Reports on the CDMRP website: http://cdmrp.army.mil/. Stay informed about CDMRP’s research funding opportunities and research results by subscribing to email notifications at https://ebrap.org/, following us on Twitter https://twitter.com/CDMRP or on YouTube http://www.youtube.com/CDMRP.
The Joint Medical Logistics Functional Development Center (JMLFDC)
The Joint Medical Logistics Functional Development Center is located at Fort Detrick to ensure functional activity program management initiatives are evolved, coordinated and tightly integrated with the applicable activities of the following: Defense Health Agency (DHA) Medical Logistics Division, U.S. Army Medical Material Agency (USAMMA), Naval Medical Logistics Command (NMLC), Air Force Medical Operations Agency (AFMOA) and the Defense Logistics Agency Troop Support Medical.
The mission of the JMLFDC is to deliver business capabilities through innovative and integrated automated solutions across the Defense Medical Logistics Enterprise (DMLE) and other Federal agencies to support and improve the delivery of healthcare. Defense Medical Logistics Enterprise Solution (DML-ES) provides medical logistics capabilities accessible by the user community at the point of execution with data visibility extending across the DMLE providing data management and replication from authoritative source(s).
The JMLFDC, as the government integrator, is the functional developer and sustainer for the Defense Health Services Systems (DHSS) Medical Logistics suite of applications. Core competencies include integrated acquisition management and requirements development for medical logistics information technology; development and sustainment of medical logistics IT applications with embedded functional subject matter experts and embedded developers working with functional team; and relationship management with customers, stakeholders, partners and suppliers. The JMLFDC provides an accountable and highly responsive capability for medical logistics IT development and sustainment within the DMLE.
The products produced by the JMLFDC provide state-of-the-art, automated tools which enable the Military Health System to save money on the cost of pharmaceuticals, medical/surgical items and equipment. The JMLFDC’s goal is to be the premier information technology solution provider for medical logistics across the federal government.
The Logistics Readiness Center
The Logistics Readiness Center is location at 9200 Veterans Drive. The LRC provides professional and timely base operational logistical programs and services that enable readiness support to the Garrison area of responsibility, mission partners and agencies installation-wide. The LRC provides swift and efficient logistical support while producing quality customer service that meets or exceeds our customers’ expectations, including Service Members, families, and civilians at Fort Detrick and Forest Glen.
The LRC provides logistical support to the Fort Detrick community all from a centralized 35,000 square foot facility which includes but is not limited to:
- Transportation Motor Pool (GSA Lease Vehicle Dispatching and Parking Bus and Forklift training)
- Freight (Hazardous, Biodefense, Small packages) (FEDEX/UPS), truck load and unit movement)
- Motor Vehicle Operations
- Central Receiving and Shipping Warehouse
- Supply Support Activity
- Combined Defense Utilization Warehouse (turn-ins)
- Property Book Operations
- Fuel Management and Maintenance.
The Army Sustainment Command (ASC), 406th Army Field Support Brigade (AFSB), Logistic Readiness Center is sharing the facility with USAG Safety and Official Mail.
For more information call (301) 619-3275
Medical Communications for Combat Casualty Care (MC4)
The Medical Communications for Combat Casualty Care program integrates and fields the Army capability to digitally capture medical treatment data in operational environments, enhancing continuity of care and enabling a comprehensive lifelong electronic medical record for Service Members. MC4 is providing the Army’s solution to presidential and congressional objectives, set forth by Title 10 in 1997, which called for a medical tracking system for all deployed Service Members.
MC4 is a semi-ruggedized system-of-systems containing medical software packages fielded to tactical medical forces throughout the combat zone and in the United States. Comprised of joint software, commercial and government-off-the-shelf products, MC4 provides the tools needed to digitally record and transfer critical medical data from the foxhole to medical treatment facilities worldwide.
Deployable medical forces use the MC4 system to gain quick, accurate access to patient histories and forward casualty resuscitation information. The system also provides units with automated tools facilitating patient tracking, medical reporting and medical logistics support. Combatant commanders use the MC4 system to access medical surveillance information, resulting in enhanced medical situational awareness.
Most importantly, MC4 is helping deployed Service Members. By equipping deployed medical units with automated resources, MC4 helps ensure Service Members have a secure, accessible, lifelong electronic medical record, which results in better-informed health care providers and easier access to Veterans Affairs medical benefits.
With more than 10 years of experience managing the DoD’s first battlefield medical recording system, MC4 remains the most widely used, comprehensive information management medical system on the battlefield. MC4’s vision is to deliver timely, cost-effective and easy-to-use information technology solutions to enable improved operational health care and patient documentation.
The Army’s Program Executive Office, Enterprise Information Systems (PEO EIS), Fort Belvoir, Virginia, oversees the MC4 Product Management Office headquartered at Fort Detrick, Maryland. Visit the MC4 website at: www.mc4.army.mil.
The National Biodefense Analysis and Countermeasures Center (NBACC)
The National Biodefense Analysis and Countermeasures Center is the first national laboratory created by the U.S. Department of Homeland Security. The NBACC addresses unmet needs in homeland security and provides a continuously available national security biocontainment laboratory capability for newly identified biological threats.
The NBACC is a one-of-a-kind facility dedicated to defending the Nation against biological threats utilizing a unique set of capabilities within the facility that did not exist prior to the Amerithrax attacks of 2001. Its work supports intelligence assessments, preparedness planning, response, emerging threat characterization and bioforensic analyses.
The NBACC is a Federally Funded Research and Development Center managed and operated by the Battelle National Biodefense Institute (BNBI) for the U.S. Department of Homeland Security, Science and Technology Directorate (DHS S&T). The NBACC mission is to provide the scientific basis for characterization of biological threats and bioforensic analysis to support attribution of their planned or actual use. Our vision is for the NBACC to be the national security biocontainment laboratory that responds to, and provides data required to support prevention, protection, mitigation and recovery from current and future biocrime and bioterrorism threats.
The National Interagency Biodefense Campus (NIBC)
The NIBC is the home of some of the most important scientific work today, including studies on disease, cancer and characterizing and protecting citizens from biological threats.
With multiple studies published annually, the NIBC is on the front lines of critical health research as well as supporting homeland security initiatives from working with and protecting first responders to protecting Soldiers deployed throughout the world.
The NIBC is a collaborative environment, where scientists from many agencies are able to share techniques, increase opportunity of discovery, and develop relationships for future collaboration. This coupled with unique business and educational relationships makes the NIBC a unique opportunity to serve the community, serve science, and contribute to peaceful scientific endeavors.
The NIBC is the home of some of the nation’s leading scientific staff. The people at these facilities take great pride in their work and their positive impact on the community. The majority of our staff live in this community and take great care in protecting and developing it.
The National Interagency Confederation for Biological Research (NICBR)
The NICBR comprises eight Federal agencies engaged in biological research associated with Fort Detrick in Frederick, Md. The NICBR currently includes the National Interagency Biodefense Campus and the Frederick National Laboratory for Cancer Research.
Vision
Federal research partners working in synergy to achieve a healthier and more secure nation.
Mission
The mission of the NICBR is to develop unique knowledge, tools, and products by leveraging advanced technologies and innovative discoveries to secure and defend the health of the American people.
Partner Agencies
United States Army, United States Army Medical Command (United States Army Medical Research and Materiel Command and United States Army Medical Research Institute of Infectious Diseases)—member since 2002.
United States Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases—member since 2002.
United States Department of Health and Human Services, National Institutes of Health, Frederick National Laboratory for Cancer Research (formerly NCI-Frederick)—member since 2002.
United States Department of Agriculture, Agricultural Research Service, Foreign Disease–Weed Science Research Unit—member since 2003.
Department of Homeland Security, Science and Technology Directorate, National Biodefense Analysis and Countermeasures Center—member since 2003.
United States Department of Health and Human Services, Centers for Disease Control and Prevention—member since 2005.
United States Navy, Naval Medical Re-search Center, Biological Defense Research Directorate—member since 2010.
United States Department of Health and Human Services, Food and Drug Adminstration—member since 2012.
Army Health Promotion and Substance Abuse Program Purpose
Naval Medical Logistics Command (NMLC)
The Naval Medical Logistics Command (NAVMEDLOGCOM) is an echelon four command under the Navy Medicine Support Command (NMSC), Jacksonville, FL. NAVMEDLOGCOM has three Areas of Responsibility under its command, the Naval Ophthalmic Support and Training Activity located at Naval Weapons Station, Yorktown, Va., the Navy Expeditionary Medical Support Command located at Cheatham Annex, Williamsburg, Va., and the NAVMEDLOGCOM Pirmasens Germany Detachment.
NAVMEDLOGCOM is the center of logistics expertise for Navy Medicine, designing, executing and administering individualized state-of-the-art solutions to meet customer’s medical material and healthcare needs. Headquartered at Fort Detrick, Md., NAVMEDLOGCOM supports the Department of the Navy with acquisition and logistics systems training, healthcare services strategies, operational forces support, medical equipment and logistics solutions, acquisition management, deployable platforms and eyewear fabrication. NAVMEDLOGCOM has formal agreements with the U.S. Marine Corps and U.S. Coast Guard to provide medical logistics and materiel management information and medical mobilization planning assistance. In addition, NAVMEDLOGCOM has responsibility as technical manager of the Navy’s direct healthcare services contracting program.
NAVMEDLOGCOM is comprised of six directorates. The Operational Forces Support Directorate provides medical and dental materiel management, logistical support, and consulting support to active Naval operating force units within U.S. Fleet Forces Command and to the shipbuilding Program Executive Office’s for platforms in pre-commissioning and overhaul status. Contact: NMLC-OFS@med.navy.mil.
The Navy Expeditionary Medical Logistics Program
The Navy Expeditionary Medical Logistics Program is chartered to acquire and maintain expeditionary deployable medical platforms as Advanced Base Functional Components to support the Fleet and the Fleet Marine Force. Contact: NMLC-EML@med.navy.mil.
The Acquisition Management Directorate
The Acquisition Management Directorate is the heart of the Navy’s Bureau of Medicine and Surgery (BUMED) contracting program. The directorate is made up of a dedicated professional staff of contracting officers and negotiators, specializing in executing contracts for medical services, medical supplies, and equipment for the Fleet, Fleet Hospitals, and Medical Treatment Facilities worldwide. Contact: NMLC-ProcurementMgmt@med.navy.mil.
The Healthcare Services Strategies Directorate
The Healthcare Services Strategies Directorate has served as a focal point for Navy healthcare contracting analysis, BUMED healthcare data reporting, requirements development, and lessons learned. Further, the directorate keeps pace with healthcare industry trends and provides a consultative service for customers advising on all forms of alternative healthcare delivery and advocating best business practices. Contact: NMLCHealthcare-support@med.navy.mil.
The Medical Equipment and Logistics Solution Directorate (MELS)
The Medical Equipment and Logistics Solution Directorate ensures technical support and management of equipment programs having Navy-wide medical and dental applications. MELS manages BUMED’s OP,DHP and O&M,DHP equipment programs and provides biomedical and clinical engineering technical support and assistance for all equipment procurement programs. Contact: NMLC-MELS@med.navy.mil.
The Navy’s Senior Service Representative (NSSR) is responsible for coordinating, communicating, and representing the Naval Medical Department’s logistics input, position, and policy pertaining to the Defense Medical Logistics Standard Support, Wide Area Work Flow, and Standard Procurement System. The NSSR represents Navy interests on various tri-service logistics and IT boards and councils. Contact: NMLC-NSSR@med.navy.mil.
http://www-nmlc.med.navy.mil/
The Naval Medical Research Center (NMRC)
The Naval Medical Research Center (NMRC) is the headquarters for Navy medicine’s research and development enterprise that includes the NMRC laboratory and seven affiliated laboratories in the U.S. and overseas.
The NMRC laboratory’s research focuses on infectious diseases, operational and undersea medicine, bone marrow research and registry, and biological defense research.
The laboratory’s infectious disease researchers are focusing on minimizing the impact of infectious diseases by preventing infection or clinical diseases. The geographical distribution of a disease; the rapid emergence of drug resistance, and the lack of an effective vaccine, treatment, or other control measures; the mode of transmission; and the medical impact during past operations are factors determining the importance of infectious diseases to the U.S. military. In most cases, the best approach is the development of vaccines.
Operational and undersea medicine researchers are focusing on the medical issues of Sailors and Marines in operational environments. Researchers are developing novel strategies to prevent and treat combat casualties with a focus on early, far forward interventions. One team studies traumatic brain injury including blast injuries, along or in combination with hemorrhage or other injuries. Another team is developing interventions to improve performance and reduce injury in Navy submariners and military divers. They are developing new technologies to prevent and treat decompression sickness and pulmonary and central nervous system toxicity associated with exposure to hyperbaric oxygen. A third team is studying composite tissue transplantation, stem cell biology and translational medicine.
The C. W. Bill Young Marrow Donor Recruiting and Research Program is developing treatment methods for damaged bone marrow. Casualties with marrow toxic injury can recover normal function because a small number of remaining cells can restore function with medical support or more severely damaged marrow can be replaced by transplantation of hematopoietic cells from a normal, genetically matched donor. The C. W. Bill Young Marrow Donor Recruitment and Research Program is connected with the National Bone Marrow Program.
The Biological Defense Research Group, located at Fort Detrick, is researching ways to protect U.S. military personnel and civilians from the threat of infectious diseases and biological attack. The group is focused on genomics and bioinformatics, molecular diagnostics, immunodiagnostics, clinical research and operational and international field microbiology.
The NMRC is located at the Forest Glen Annex in Silver Spring, Maryland, and shares the Senator Daniel Inouye Building with the Walter Reed Army Institute of Research.
The diverse capabilities and geographic location of the other affiliated laboratories reflect a broad scope of research. The Naval Submarine Medicine Research Laboratory is studying enclosed atmospheres, submarine escape procedures, decompression sickness and hearing preservation. The Naval Health Research Center is focused on Warfighter performance, medical modeling and wounded warrior care. The researchers are leaders in epidemiological and behavioral studies including the largest longitudinal study, the Millennium Cohort study and the gold-standard in behavioral health surveillance. The Naval Medical Research Unit – Dayton is exploring performance and survivability through world-class aeromedical and environmental health research that includes research looking into pharmaceuticals for motion sickness and fatigue countermeasures. The Naval Medical Research Unit – San Antonio is collaborating with neurosurgeons, and oral and maxillofacial surgeons, to reduce postsurgical infections related to cranial implants to replace lost bone tissue.
Emerging and re-emerging infectious diseases remain a threat to operational forces. The NMRC has three overseas infectious disease research commands. They are in Cairo with a field site in Accra, Ghana; Singapore with a field site in Phnom Penh, Cambodia; and Lima, Peru, with a field site in Iquitos, Peru. The mission of these labs is to conduct infectious disease research and improve disease surveillance and outbreak response assistance for infectious diseases of critical public health importance to the United States and regional partners. The location of these labs and their principal field sites are on three continents and in climatic conditions ranging from tropical rain forest to coastal areas and inland deserts and are ideally suited to the study of the widest range of potential infectious disease threats to operational forces.
The NMRC is committed to improving current readiness and enhancing future capabilities.
National Museum of Health and Medicine (NMHM)
Founded in 1862 as the Army Medical Museum, today’s National Museum of Health and Medicine (NMHM) is the Nation’s medical museum and a Department of Defense asset; serving a broad mission of inspiring interest and understanding in the history of medicine, with a special emphasis on tri-service American military medicine.
Located on the Forest Glen Annex, the NMHM offers an incredible array of exhibits showcasing their National Historic Landmark collection of 25 million objects. Exhibits feature Civil War medicine, traumatic brain injuries and advances in military medicine, including the floor of a U.S. Air Force emergency room used during Operation Iraqi Freedom. A special exhibit in 2015 will spotlight the 150th anniversary of the assassination of President Abraham Lincoln and the exhibit will include the bullet that killed the president.
The NMHM is open daily, including weekends and holidays (except Dec. 25) from 10 a.m. to 5:30 p.m. Admission and parking are free. The NMHM offers a diverse array of public programs, including its monthly Medical Museum Science Café and special programs for children. Details about those programs are available via NMHM’s website and Facebook page.
For more information, visit:
NMHM online at: www.medicalmuseum.mil
Facebook: www.facebook.com/MedicalMuseum
Twitter www.twitter.com/MedicalMuseum.
NMHM staff can also be contacted by e-mail at USArmy.Detrick.MEDCOM-USAMRMC.List.Medical-Museum@mail.mil or by phone at (301) 319-3300 for more information.
Network Enterprise Center (NEC)
Subordinate to 93rd Signal Brigade/7th Signal Command (Theater)/Network Enterprise Technology Command, the NEC provides command, control, communications, and computer information management (C4IM) services to the Army’s only multi-agency (including the Department of Defense’s joint commands and programs, Army, Navy, Air Force, Marine Corps, the National Institutes of Health, United States Department of Agriculture, Department of Homeland Defense and others) campus for Medical Research and Acquisition, Medical Logistics Management and Communications Infrastructure Research & Engineering. Such an environment requires a flexible, multi-talented IM/IT provider to facilitate the varied and extensive requirements inherent to mission success for this wide range scope and variety of disciplines. It is charged with operation and defense of the Installation Campus Area Network (ICAN), connectivity to the LandWarNet (LWN) and to provide cost-effective and high quality cyber and communication services to our customers at Fort Detrick and the Department of the Army. The NEC provides enterprise services support through technology, infrastructure, tools and resources to support military, medical and other agencies’ operations. Baseline C4IM services to traditional Army customers is centrally funded. Baseline C4IM services to non-Army customers and all above baseline services are provided on a reimbursable basis.
The Telemedicine and Advanced Technology Research Center (TATRC)
Exploring, Innovating, and Managing Medical Technologies that Advance Military Medicine.
The Telemedicine & Advanced Technology Research Center (TATRC) fosters research on health informatics, telemedicine/m-Health, medical training systems and computational biology to address gaps in DOD medical research programs and military healthcare.
Our mission is to exploit technical innovations for the benefit of military medicine by developing, demonstrating and integrating across a variety of technology portfolios to include: teleHealth, medical simulation and training, health IT, medical robotics, command and control and mobile solutions. The TATRC sponsors bottom-up innovation through limited technology demonstrations focused on readiness, access to care and healthcare delivery.
The TATRC is an office of the headquarters of the U.S. Army Medical Research and Materiel Command (USAMRMC), located at Fort Detrick, Maryland. The TATRC conducts and supports research through its six key laboratories and programs which include: Computational Biology, Health I.T., Mobile Health, Medical Modeling and Simulation, Operational Telemedicine and the AAMTI Program. With an extensive network of partners, the TATRC expertise is focused on the entire research spectrum, from early stage innovative research to technology demonstrations and implementation to benefit the Warfighter. TATRC labs actively collaborate with commercial entities and academic institutions to address the requirements of our medical research programs through special funding and partnership opportunities.
For more information on the TATRC and its programs, please call TATRC Public Affairs at (301) 619-7927 or visit: www.tatrc.org.
U.S. Army Center for Environmental Health Research (USACEHR)
The USACEHR is a medical research and development laboratory focused on adverse health effects resulting from service-related physiological and psychological stresses. The laboratory develops next generation diagnostic and health surveillance tools and medical solutions for these health effects using integrative analytical approaches and systems biology. USACEHR scientists inter-relate diverse clinical, psychological, “omics,” toxicological and epidemiological data into a comprehensive view of a service-related health effect in order to understand its cause, mitigate it and prevent it. Areas of active research include the systems biology of post-traumatic stress disorder and trauma coagulopathy (Integrative Systems Biology Program), deployment-related lung disease (Pulmonary Health Research Program) and identification of biomarkers for exposures to toxic environmental materials (Environmental Health Program). The USACEHR also hosts the Systems Biology Collaboration Center (SBCC), which promotes the use of systems biology and collaboration across all USAMRMC laboratories to accelerate the development of military-relevant medical solutions. As part of its mission, the SBCC operates the SysBioCube, a data warehouse and high performance computational biology resource for military biomedical research. The USACEHR is continually looking for partners across the Department of Defense, other government organizations, industry and academia to enhance our research base and share resources. Contact information is provided below.
Key Capabilities:
• Skills and tools for identifying and understanding the causes of complex health issues and finding solutions and mitigations for them.
• Skills and tools for identifying biomarkers of exposures to environmental toxicants.
• Instrumentation for “next-gen” sequencing, proteomics, microarrays and analytical chemistry.
• Advanced aquaculture and aquatic toxicity testing facilities for fish and amphibians.
• Rodent vivarium with gnotobiotic (“germfree” animal) capabilities.
For more information, call (301) 619-7685 or visit: http://usacehr.amedd.army.mil/
U.S. Department of Agriculture, Foreign Disease Weed Science Research Unit
(USDA-ARS)
The Foreign Disease-Weed Science Research Unit (FDWSRU) at Fort Detrick, Maryland, is operated by the U.S. Department of Agriculture (USDA), Agricultural Research Service (ARS)—the principal intramural scientific research agency of the USDA. FDWSRU’s scientists conduct research in furtherance of two ARS National Programs: Plant Diseases and Crop Protection and Quarantine. FDWSRU researchers utilize a unique BSL-3 plant pathology greenhouse containment facility for their studies. Research in support of the Plant Diseases Program includes development of diagnostic procedures for rapid and accurate detection, as well as identification of new and emerging crop diseases such as Asian soybean rust, wheat blast, citrus greening and sudden oak death. The research is also conducted in furtherance of risk assessments and the formulation of practical phytosanitary regulations guiding the import and export of agricultural commodities and plant germplasm, including seed. Biological weed control is the focus of research in support of the Crop Protection and Quarantine Program. It involves characterizing exotic plant pathogens collected from outside the United States and evaluating their safety and potential use as biocontrol agents against invasive weed species.